Premium Information is available for this item - Upgrade for $1 a day
6505-00-913-4577
And Prednisolone Acetate Ophthalmic Suspension Phenylephrine Hydrochloride Sulfacetamide Sodium
6505009134577 009134577 BLEPHAMIDE AK-CIDE NDC00023-0024-05 NDC17478-0217-10
INC: 27852 And Prednisolone Acetate Ophthalmic Suspension Phenylephrine Hydrochloride Sulfacetamide Sodium
January 2023
6
Marketplace 6505-00-913-4577
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-913-4577 5+ Documents (More...)
1 Jan 1960 1 Jan 1960 AK-CIDE 6505009134577009134577 ,BLEPHAMIDE ,BLEPHAMIDE 6505009134577009134577,
BLEPHAMIDE 6505009039220009039220 009039220,BLEPHAMIDE ,BLEPHAMIDE ,BLEPHAMIDE ,BLEPHAMIDE ,BLEPHAMIDE
Generic https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-913-4577 6505009134577 009134577,BLEPHAMIDE
,BLEPHAMIDE ,BLEPHAMIDE ,BLEPHAMIDE ,BLEPHAMIDE Count 9 NATO Data Quality https//www.nsnlookup.com /
BLEPHAMIDE S.O.P. https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-126-20406505001262040001262040
BLEPHAMIDE S.O.P. -6505/us 6505-00-903-92206505009039220009039220,BLEPHAMIDE fsg-65/fsc-6505/us 6505-
BLEPHAMIDE S.O.P. 6505011304679011304679,BLEPHAMIDE S.O.P. 6505001262040001262040 6505011304679011304679
00-903-9220 6505009039220 009039220,BLEPHAMIDE ,BLEPHAMIDE ,BLEPHAMIDE ,BLEPHAMIDE ,BLEPHAMIDE ,BLEPHAMIDE
Day 6505-01-233-7850 RQST NE Related Documents Day 6505 -01-233 -7850 RQST 6505012337850012337850,AK-CIDE
Stock Numbers https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-233-78506505012337850 012337850,AK-CIDE
Restrictions 6505-00-913-4577
6505-00-913-4577 is a And Prednisolone Acetate Ophthalmic Suspension Phenylephrine Hydrochloride Sulfacetamide Sodium that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-00-913-4577
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-00-913-4577
- MOE Rule:
- V542
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-913-4577
- Part Number
- Manufacturer
- Status
- BLEPHAMIDE
- Manufacturer
- 24172 - Allergan Inc (Active)
- Incomplete Reference
- Incomplete Reference
- NDC00023-0024-05
- 24172 - Allergan Inc (Active)
- Primary Buy
- Primary Buy
- NDC17478-0217-10
- 60061 - Akorn Inc (Active)
- Primary Buy
- Primary Buy
- AK-CIDE
- 60061 - Akorn Inc (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-00-913-4577
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 10.000 Percentage, W/V Sulfacetamide Sodium Active Ingredient And 0.120 To 0.125 Percentage,W/V Phenylephrine Hydrochloride Active Ingredient And 0.200 To 0.500 Percentage,W/V Prednisolone Acetate Active Ingredient
- Primary Container Content Quantity [CRLK]
- 5.000 Milliliters
- Primary Container Type [CQCT]
- Vial
Management Data 6505-00-913-4577
- Effective Date
- Organization
- Unit of Issue
- Unit Price
- Qty Unit Pack
- Unit of Issue
- Oct 1991
- Veterans Administration (VA)
- BT
- Subscribe
- BT
- MOE
- USC
- Code
- Statement
- Order of Use
- Jump To Code
- Qty Per Assy
- UOM
- Technical Document
- Quantative Expression
- Code
- Veterans Administration (VA)
- V
- K
- U/I Contains 5 Ml
- 00000000005ML
- K
Similar Supply Items to 6505-00-913-4577
Freight Information 6505-00-913-4577
6505-00-913-4577 has freight characteristics.. 6505-00-913-4577 has a variance between NMFC and UFC when transported by rail and the description should be consulted.